检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:涂巍[1] 温健[1] 乔婉晴[1] 赵嫚[1] 于作夫[1]
机构地区:[1]中国医科大学附属第四医院乳腺外科,沈阳110032
出 处:《国际外科学杂志》2010年第1期32-35,共4页International Journal of Surgery
摘 要:目的研究内源性一氧化氮(NO)对人乳腺癌细胞化疗敏感性的影响。方法应用IL—1β处理培养的MCF-7细胞,检测NO的产生情况并用蛋白质印迹法检测诱导型一氧化氮合酶(induceble nitric oxide synthase,iNOS)蛋白的表达。MTT法检测MCF-7细胞在NOS抑制剂NG-甲基-L-精氨酸(NG-monomethyl-L-arginine,L-NMMA)和NO合成原料L-精氨酸(L—arginine,L—Arg)作用下对多柔比星(adriamycin,ADM)和5-氟尿嘧啶(5-fluorouracil,5-Fu)药物的敏感性。结果内源性NO的产量与IL-1β剂量呈正相关。在IL-1β诱导作用下MCF-7细胞大量表达iNOS蛋白,并与L-Arg、L—NMMA存在与否无关。当ADM浓度为0.5μmol/L和1μmol/L时,实验组细胞的生存率明显下降(P〈0.05)。加入L-NMMA能显著提高实验组细胞的生存率(P〈0.05);加入L—Arg能显著提高MCF-7细胞对化疗药物的敏感性(P〈0.05)。结论在细胞因子IL-1β诱导下MCF-7细胞产生的内源性NO增加,并使MCF-7细胞化学敏感性提高.Objective To evaluate the effects of endogenous NO on the ehemosensitivity of human breast cancer cell. Methods MCF-7 cells were euhured as monolayer, incubated with eytokine IL-1β. The produetion of NO was detected by NO assay. The expression of iNOS protein was measured by Western blotting. Establishing control group and experimental group, the chemosensitivity of MCF-7 cells incubated by L- NMMA and L-Arg to ADM and 5-Fu was studied by MTT assay. Results There was a positive correlation of dose-dependence between NO production and IL-1β concentration. MCF-7 cells expressed plenty of iNOS by induction of IL-1β. There was no significant difference on iNOS whether L-NMMA and L-Arg existed or not, Incubating MCF-7 cells with 0.5 μmol/L or 1 μmol/L ADM, the survival rate of experiment group was remarkablely decreased(P 〈 0.05 ) ; L-NMMA significantly increased survival rate of experiment group( P 〈 0.05) ; L-Arg decreased survival rate of experiment group( P 〈 0.05). Conclusion The induction of IL- 1β in MCF-7 cells can increase the production of endogenous NO, which increases MCF-7 cells' sensitivity to chemotherapy.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.145.146.15